[144] Agios Pharmaceuticals, Inc. SEC Filing

Rhea-AI Filing Summary

Agios Pharmaceuticals filed a Form 144 reporting a proposed sale of 11,085 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $410,810.10 and an approximate sale date of 08/08/2025. The filing shows 58,101,518 shares outstanding, so the proposed sale represents about 0.019% of outstanding shares.

The securities to be sold were recorded as acquired on 08/08/2025 by vesting of restricted stock units from the issuer. The filing also lists a prior sale by Brian Goff of 18,700 shares on 06/24/2025 for $627,198.00. Certain filer-identifying fields (CIK and the named person for whose account the current sale is being made) are not populated in the provided content.

Insights

Securities Analyst

TL;DR: Routine RSU-based sale notice of 11,085 shares; size is small relative to total outstanding shares, prior insider sale recorded.

This Form 144 documents a proposed market sale of 11,085 shares valued at $410,810.10 through Morgan Stanley on 08/08/2025, with acquisition listed as RSU vesting on the same date. The sale size (~0.019% of outstanding shares) is immaterial to share count and unlikely to move markets by itself. The filing also records a prior sale of 18,700 shares on 06/24/2025 for $627,198 by Brian Goff. Absent additional context or larger aggregated insider selling, this notice appears routine and compensation-related.

Corporate Governance Expert

TL;DR: Compensation vesting prompted this notice; incomplete filer identification limits clarity on insider role and aggregation implications.

The entry shows the securities were acquired by vesting of restricted stock units, indicating a compensation event rather than an open-market purchase. That typically explains a subsequent Form 144 notice for planned sales. However, key form fields such as filer CIK and the explicit "Name of Person for Whose Account the Securities are To Be Sold" are not populated in the provided text, which reduces transparency on the filer’s insider status and whether other aggregated sales apply. Governance review should note the prior June sale by Brian Goff when assessing total recent insider dispositions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	11085	410810.10	58101518	08/08/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/08/2025	Vesting of Restricted Stock Units	Issuer			11085	08/08/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Brian Goff 88 Sidney Street Cambridge MA 02139	Common Stock	06/24/2025	18700	627198.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Agios (AGIO) Form 144 disclose?

The Form 144 reports a proposed sale of 11,085 common shares via Morgan Stanley, with an aggregate market value of $410,810.10 and an approximate sale date of 08/08/2025.

How were the 11,085 shares acquired according to the filing?

The filing lists the acquisition as vesting of restricted stock units on 08/08/2025, with payment recorded the same date.

How large is the proposed sale relative to outstanding shares of AGIO?

The filing shows 58,101,518 shares outstanding; 11,085 shares equal about 0.019% of outstanding shares.

Did the filer sell any AGIO shares recently?

Yes. The document records a sale by Brian Goff of 18,700 shares on 06/24/2025 for $627,198.00.

Who is the broker handling the proposed sale?

The proposed sale is listed with Morgan Stanley Smith Barney LLC Executive Financial Services located at 1 New York Plaza, 8th Floor, New York, NY 10004.